TOP STORIES

• REGULATORY Pfizer’s Comirnaty Bags Japan Approval for Ages 5-11; Actemra OK’ed for COVID-19
  January 21, 2022

• REGULATORY Pfizer’s Comirnaty Clears Key Panel for Ages 5-11; Actemra Set for COVID-19 Nod
  January 21, 2022

• REGULATORY Macroeconomic Indexing Lacks Perspectives to Promote Innovation, Improve Care: MHLW Bureau Chief
  January 20, 2022

• REGULATORY Re-Pricing to Hit 23 Drugs in April; Takecab, GLP-1s, Vyndaqel/Vynmac, and More
  January 19, 2022

• REGULATORY Takecab Faces 2nd “Huge-Seller” Price Slash, All GLP-1 Injectables to Get Cut Too on Market Expansion
  January 18, 2022

• COMMENTARY Significance and Challenges around Proposed Emergency Approval Scheme, Eyes on Diet Debate
  January 17, 2022

• BUSINESS Pfizer Files Oral COVID-19 Pill in Japan
  January 14, 2022

• REGULATORY Pfizer’s Comirnaty Up for PAFSC Review for Ages 5-11 on Jan. 20; Actemra to Add COVID-19 Use
  January 14, 2022

• BUSINESS Keytruda, Opdivo Neck and Neck in 2021; 6 Drugs Cross 100 Billion Yen Mark: Encise
  January 13, 2022

• REGULATORY AMED to Set Up SCARDA in March to Spearhead Vaccine Development: President
  January 12, 2022

• REGULATORY MHLW Eyes Evaluation Indices and Guidelines to Fuel Rollout of SaMD and Cell & Gene Therapies: Official
  January 11, 2022

• REGULATORY Rewarding Innovation Was the Primary Goal in 2022 Reform Debate: MHLW Official
  January 7, 2022

• REGULATORY MHLW to Reshuffle Organization by Summer to Further Support Drug Development; Economic Affairs Division to Be Renamed
  January 7, 2022

• ORGANIZATION FPMAJ to Go Full Force on Honebuto Debate towards Next Off-Year Price Revision: Chief
  January 6, 2022

• BUSINESS Shionogi’s COVID-19 Pill Submission Delaying into 2022 as Recruitment Hits Snag
  January 6, 2022

• BUSINESS Nexium and Feburic Generic Debuts Eyed in 2022, but with Caution to Avoid Shortages
  January 5, 2022

• REGULATORY Japan Govt to End Observational Avigan Study for COVID-19
  January 5, 2022

• BUSINESS 5 Atopic Dermatitis Drugs Debut in Japan since 2018; Focus Now on Roles of Dupixent, JAK Inhibitors
  December 28, 2021

• TRENDS 15 APIs with 10 Billion Yen-Plus Peak Sales Outlooks Listed in 2021: Jiho Tally
  December 28, 2021

• TRENDS Top 10 PHARMA JAPAN Articles in 2021
  December 28, 2021

ページ

• « 先頭
• ‹ Prev
• …
• 85
• 86
• 87
• 88
• 89
• 90
• 91
• 92
• 93
• …
• Next ›
• 最終 »